Virginia Cappagli

5PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2025
Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy.

Virginia Cappagli, Antonio Matrone, Valeria Bottici

|Apr 03, 2021
Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.

Loredana Lorusso, Virginia Cappagli, Laura Valerio

|May 05, 2020
Proteinuria is a late-onset adverse event in patients treated with cabozantinib.

V Cappagli, D Moriconi, A G Bonadio

Pageof 1